from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1679/fadE16

LFCtreatmentdescriptionclass of inhibitor

-0.532

Amikacinug/mL Amikacintranslation

-1.417

Cap5-10ug/mL Capreomycintranslation

-1.532

Rox10-50 ug/mL Roxithromycintranslation

0.727

SM2-5 ug/mL Streptomycintranslation

0.773

Tet5-10 ug/mL Tetracyclinetranslation

0.489

Rif0.2-5ug/mL Rifampicintranscription

0.747

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.701

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.238

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.554

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.863

Clofazimine10-13 ug/mL Clofaziminerespiration

0.097

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.782

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.846

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.747

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.607

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.978

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.123

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.719

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.033

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.195

KCN5-20 ug/mL Potassium cyaniderespiration

-0.424

NaN30.2-2 mM Sodium aziderespiration

0.017

Nigericin50 uM Nigericinrespiration

-0.709

TRC10-150 ug/mL Triclosanrespiration

-1.702

TRZ10-25 ug/mL Thioridazinerespiration

-1.860

Valinomycin0.5-10 uM Valinomycinrespiration

0.166

ZnSO42 mM ZnSO4respiration

-0.390

menadione6-10 ug/mL Menadionerespiration

-0.728

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.016

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.201

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.209

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.147

NRP_1Non-replicating persistence stage 1dosRassociated

0.288

Amp0.2mg/mL AmpicillincellWall

0.514

Cephalexin20-100 ug/mL CephalexincellWall

-0.576

Cerulenin0.32-5 ug/mL CerulenincellWall

0.285

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.028

EMB10-20 ug/mL EthambutolcellWall

0.140

Eta12-40 ug/mL EthionamidecellWall

0.235

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.056

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.008

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.044

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.988

BZA0.12 mg/mL BenzamidearomaticAmides

0.467

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.571

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.341

H2O24 mM hydrogen peroxideDNAdamaging

-0.149

Levo10 ug/mL LevofloxacinDNAdamaging

0.726

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.585

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.604

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.870

UVUV-irradiationDNAdamaging

1.716

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.080

Antimycin12.5-50 ug/mL Antimycin A?

-0.386

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.575

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.298

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.068

PA8240.2-2 ug/mL PA-824?

0.087

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.587

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.448

Verapamil50 uM Verapamil?

0.042

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.481

methoxatin10-20 ug/mL Methoxatin?